Insecticides (India) Ltd (INSECTICID) Q3FY25 Concall Summary - Dec-2024 Qtr
Performance Overview
- Insecticides India Ltd. reported strong operational performance and successful execution of strategic initiatives in Q3 Dec-2024.
- The company achieved its highest ever PAT of INR 128 crores, a 35% YoY growth.
- Premiumization strategy proved successful, with premium products contributing 62% of B2C sales in nine months, up from 50%.
- Volume growth in premium products reached 19% YoY, while overall B2C volume growth was 12%.
- Industry faced headwinds impacting B2B sales, but the company maintained an 11.7% EBITDA margin over nine months and expects double-digit margins for the full year.
- The company aims for 20% growth in premium product sales (Maharatna products) over the next four to five years.
- Gross margin target of 30% to 35% and EBITDA margin of 12% to 13% set for the next one to two years.
- The company plans to expand its leadership team with CXO positions and senior management hires across marketing, sales, R&D, manufacturing, and operations.
- Working capital cycle improvement of 20 to 25 days planned for the next year.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.